PRECIGEN, INC.·4

Mar 20, 7:15 PM ET

Lehr Donald P. 4

4 · PRECIGEN, INC. · Filed Mar 20, 2026

Research Summary

AI-generated summary of this filing

Updated

Precigen (PGEN) CLO Donald Lehr Receives and Converts 40,443 RSUs

What Happened

  • Donald P. Lehr, Chief Legal Officer of Precigen, was granted 40,443 restricted stock units (RSUs) on 2026-03-18 that vested immediately and converted into 40,443 shares. The Form 4 shows both the award (code A) and conversion/exercise (code M) entries for 40,443 shares. The award and conversion entries report $0.00 per share (derivative), and the filing also records a disposition of 40,443 shares at $0.00; no cash proceeds or total dollar value are reported in the filing.

Key Details

  • Transaction date(s): March 18, 2026; Form 4 filed March 20, 2026.
  • Transaction codes: A = Award/Grant (40,443 RSUs); M = Exercise/Conversion (40,443 shares acquired and 40,443 shares disposed).
  • Price/value reported: $0.00 per share for the award and conversion; no sale proceeds or aggregate dollar amounts disclosed.
  • Shares owned after transaction: Not specified in the provided filing excerpt.
  • Footnotes: F1 — each RSU converts to one share of common stock; F2 — the RSUs vested immediately upon grant.
  • Timeliness: Form filed two days after the transactions; the filing does not indicate it was late.

Context

  • These entries reflect an equity award (RSUs) that vested and converted into common shares. The matching disposal shown in the filing is not explained in the report; filings of this type often show immediate dispositions or net settlements to satisfy tax withholding or administrative obligations, but the Form 4 here does not state the reason or any cash amounts. This appears to be a grant/settlement event rather than an open-market buy or sale that indicates a directional trade.

Insider Transaction Report

Form 4
Period: 2026-03-18
Lehr Donald P.
Chief Legal Officer
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-03-18+40,443722,092 total
  • Award

    Restricted Stock Units

    [F1][F2]
    2026-03-18+40,44340,443 total
    Common Stock (40,443 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F1][F2]
    2026-03-1840,4430 total
    Common Stock (40,443 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
  • [F2]The RSUs vested immediately upon the grant date.
Signature
/s/ Donald P. Lehr|2026-03-20

Documents

1 file
  • 4
    dp243983_4-lehr.xmlPrimary

    FORM 4